Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|9|874-883

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.9, 2016-03, pp. : 874-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Influences of Complementary Therapy on Motor and Non-Motor Complications in Parkinson's Disease

By Zesiewicz Theresa A.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 817-835

Adis International

Access to resources Recommend Favorite

Motor and Non-Motor Features of Parkinson's Disease – A Review of Clinical and Experimental Studies

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 4, 2012-06 ,pp. : 439-449

Bentham Science Publishers

Access to resources Recommend Favorite

DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients

By Rieck Mariana   Schumacher-Schuh Artur F   Altmann Vivian   Francisconi Carolina LM   Fagundes Paulo TB   Monte Thaís L   Callegari-Jacques Sidia M   Rieder Carlos RM   Hutz Mara H  

Pharmacogenomics, Vol. 13, Iss. 15, 2012-11 ,pp. : 1701-1710

Future Medicine

Access to resources Recommend Favorite

Treatment options for non-motor symptoms in late-stage Parkinson's disease

By Coelho Miguel   Ferreira Joaquim   Rosa Mrio   Sampaio Cristina  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 523-535

Informa Healthcare

Access to resources Recommend Favorite

Drug treatment of non-motor symptoms in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 381-388

Informa Healthcare

Access to resources Recommend Favorite